Home Africa News Australian Rare Earths Shares Surge Following Trump-Albanese Critical Minerals Deal

Australian Rare Earths Shares Surge Following Trump-Albanese Critical Minerals Deal

Share
australian-rare-earths-shares-surge-following-trump-albanese-critical-minerals-deal
Australian Rare Earths Shares Surge Following Trump-Albanese Critical Minerals Deal
Share

The two leaders signed a landmark critical minerals and rare earths framework on Oct. 20.

Australian Rare Earths Shares Surge Following Trump-Albanese Critical Minerals Deal

U.S. President Donald Trump greets Australian Prime Minister Anthony Albanese at the White House on Oct. 20, 2025. Madalina Kilroy/The Epoch Times

Monica O’Shea

|Updated:

Australian Rare Earth shares are soaring on the market following a critical minerals and rare earths deal between Washington and Canberra.

U.S. President Donald Trump and Australian Prime Minister Anthony Albanese signed an agreement to improve cooperation between the two countries to mine, process, and supply rare earths and other critical minerals.

Monica O’Shea

Monica O’Shea is a reporter based in Australia. She previously worked as a reporter for Motley Fool Australia, Daily Mail Australia, and Fairfax Regional Media. She can be reached at monica.o'[email protected]

Author’s Selected Articles

Share
Related Articles
usda-unveils-new-support-for-ranchers-to-rebuild-cattle-herds
BusinessEconomyUSUS News

USDA Unveils New Support for Ranchers to Rebuild Cattle Herds

The U.S. Department of Agriculture has unveiled a new package of measures...

how-major-us-stock-indexes-fared-aug.-31
BrightBusinessInvestingMarketsPersonal FinanceStocks

How Major US Stock Indexes Fared Aug. 31

Oil prices rose and U.S. stocks fell after American forces struck Iranian...

trump-unveils-new-drug-pricing-deals-with-9-pharmaceutical-companies
BusinessCompaniesExecutive BranchUSUS NewsUS Politics

Trump Unveils New Drug Pricing Deals With 9 Pharmaceutical Companies

President Donald Trump on Aug. 31 announced agreements with nine midsize pharmaceutical...